Neonc Technologies Holdings (NTHI) Return on Assets (2025 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Return on Assets of 0.12% for Q1 2026, down 6.0% year-over-year from 0.13% in Q1 2025, and up 32.46% quarter-over-quarter from 0.18% in Q4 2025.
Neonc Technologies Holdings (NTHI) Return on Assets (2025 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Return on Assets for 2 consecutive years, with 0.12% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets fell 6.0% year-over-year to 0.12%; the TTM figure through Mar 2026 stood at 0.12% (down 6.0% YoY), while the FY2025 annual figure was 0.26%, changed N/A from the prior year.
- Return on Assets rose to 0.12% in Q1 2026 per NTHI's latest filing, from 0.18% in the prior quarter.
- Across five years, Return on Assets topped out at 0.06% in Q1 2025 and bottomed at 0.18% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | -0.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.10% |
| Mar 31, 2026 | -0.12% |
| Dec 31, 2025 | -0.18% |
| Sep 30, 2025 | -0.14% |
| Jun 30, 2025 | -0.07% |
| Mar 31, 2025 | -0.06% |